A quantitative view on multivalent nanomedicine targeting.

Although the concept of selective delivery has been postulated over 100 years ago, no targeted nanomedicine has been clinically approved so far. Nanoparticles modified with targeting ligands to promote the selective delivery of therapeutics towards a specific cell population have been extensively reported. However, the rational design of selective particles is still challenging. One of the main reasons for this is the lack of quantitative theoretical and experimental understanding of the interactions involved in cell targeting. In this review, we discuss new theoretical models and experimental methods that provide a quantitative view of targeting. We show the new advancements in multivalency theory enabling the rational design of super-selective nanoparticles. Furthermore, we present the innovative approaches to obtain key targeting parameters at the single-cell and single molecule level and their role in the design of targeting nanoparticles. We believe that the combination of new theoretical multivalent design and experimental methods to quantify receptors and ligands aids in the rational design and clinical translation of targeted nanomedicines.

[1]  L. Liz‐Marzán,et al.  Reversible Control of Protein Corona Formation on Gold Nanoparticles Using Host–Guest Interactions , 2020, ACS nano.

[2]  Matthias Müller,et al.  Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode. , 2019, Nano letters.

[3]  M. Dogterom,et al.  Solid colloids with surface-mobile linkers , 2015, Journal of physics. Condensed matter : an Institute of Physics journal.

[4]  M. Nair,et al.  Personalized nanomedicine for CNS diseases. , 2017, Drug discovery today.

[5]  K. Dawson,et al.  Constructing bifunctional nanoparticles for dual targeting: improved grafting and surface recognition assessment of multiple ligand nanoparticles. , 2016, Nanoscale.

[6]  Omid C. Farokhzad,et al.  α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. , 2012, ACS nano.

[7]  F. Caruso,et al.  A few clarifications on MIRIBEL , 2020, Nature Nanotechnology.

[8]  M. Heilemann,et al.  Subdiffraction-resolution fluorescence imaging with conventional fluorescent probes. , 2008, Angewandte Chemie.

[9]  P. Seeman,et al.  Dopamine receptors and transporters in Parkinson's disease and schizophrenia , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[11]  Philip S Low,et al.  Ligand-Targeted Drug Delivery. , 2017, Chemical reviews.

[12]  X. Banquy,et al.  Nanoparticle heterogeneity: an emerging structural parameter influencing particle fate in biological media? , 2019, Nanoscale.

[13]  B. Liedberg,et al.  Direct quantification of surface coverage of antibody in IgG-Gold nanoparticles conjugates. , 2019, Talanta.

[14]  Jean-Christophe Leroux,et al.  Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility? , 2017, Angewandte Chemie.

[15]  P. Dedecker,et al.  An introduction to optical super-resolution microscopy for the adventurous biologist , 2018, Methods and applications in fluorescence.

[16]  A. Koster,et al.  Ultrastructural Imaging of Salmonella–Host Interactions Using Super‐resolution Correlative Light‐Electron Microscopy of Bioorthogonal Pathogens , 2018, Chembiochem : a European journal of chemical biology.

[17]  P Bongrand,et al.  Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.

[18]  C. Figdor,et al.  Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect , 2017, ACS omega.

[19]  C. Wagner,et al.  Multivalent Ligand Binding to Cell Membrane Antigens: Defining the Interplay of Affinity, Valency, and Expression Density. , 2018, Journal of the American Chemical Society.

[20]  G. MacBeath,et al.  Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients. , 2013, The American journal of pathology.

[21]  Marie-Lena I. E. Harwardt,et al.  Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation , 2020, International journal of molecular sciences.

[22]  A. Goepferich,et al.  Ligand Density and Linker Length are Critical Factors for Multivalent Nanoparticle-Receptor Interactions. , 2018, ACS applied materials & interfaces.

[23]  Delyan R. Hristov,et al.  Mapping of Molecular Structure of the Nanoscale Surface in Bionanoparticles. , 2017, Journal of the American Chemical Society.

[24]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[25]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[26]  Jason T. Duskey,et al.  Nanoparticle Ligand Presentation for Targeting Solid Tumors , 2014, AAPS PharmSciTech.

[27]  G. Heppner,et al.  Tumor heterogeneity: biological implications and therapeutic consequences , 2004, Cancer and Metastasis Reviews.

[28]  Ding Ding,et al.  Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.

[29]  Xiaobo Yu,et al.  In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance , 2014, Scientific Reports.

[30]  Vladimir P. Zhdanov,et al.  Quantification of Multivalent Interactions by Tracking Single Biological Nanoparticle Mobility on a Lipid Membrane. , 2016, Nano letters.

[31]  Giuseppe Battaglia,et al.  On the design of precision nanomedicines , 2020, Science Advances.

[32]  Melting transition in lipid vesicles functionalised by mobile DNA linkers , 2016 .

[33]  L. Albertazzi,et al.  Super-resolution Microscopy for Nanomedicine Research , 2019, ACS nano.

[34]  D. Frenkel,et al.  Designing super selectivity in multivalent nano-particle binding , 2011, Proceedings of the National Academy of Sciences.

[35]  D. Fanestil,et al.  Interference by lipids in the determination of protein using bicinchoninic acid. , 1986, Analytical biochemistry.

[36]  Gaudenz Danuser,et al.  Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane , 2017, Scientific Reports.

[37]  K. Dawson,et al.  Label-free in-flow detection of receptor recognition motifs on the biomolecular corona of nanoparticles. , 2018, Nanoscale.

[38]  B. M. Mognetti,et al.  Linker-Mediated Phase Behavior of DNA-Coated Colloids , 2019, Physical Review X.

[39]  A. Zherdev,et al.  Less is More: A Comparison of Antibody-Gold Nanoparticle Conjugates of Different Ratios. , 2017, Bioconjugate chemistry.

[40]  K. Landfester,et al.  Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.

[41]  K. Dawson,et al.  Understanding and Characterizing Functional Properties of Nanoparticles , 2016 .

[42]  Christoffer Åberg,et al.  Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.

[43]  D. Fatouros,et al.  Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements. , 2012, Advanced drug delivery reviews.

[44]  Gergana Gocheva,et al.  A Look at Receptor-Ligand Pairs for Active-Targeting Drug Delivery from Crystallographic and Molecular Dynamics Perspectives. , 2019, Molecular pharmaceutics.

[45]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[46]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[47]  Thierry Gacoin,et al.  Counting the number of proteins coupled to single nanoparticles. , 2007, Journal of the American Chemical Society.

[48]  P. Jonkheijm,et al.  Weak Multivalent Binding of Influenza Hemagglutinin Nanoparticles at a Sialoglycan-Functionalized Supported Lipid Bilayer , 2019, ACS nano.

[49]  J. Crocker,et al.  Colloidal interactions and self-assembly using DNA hybridization. , 2005, Physical review letters.

[50]  K. S. Gruβmayer,et al.  Photons in - numbers out: perspectives in quantitative fluorescence microscopy for in situ protein counting , 2018, Methods and applications in fluorescence.

[51]  Rod S. Taylor,et al.  Near-field scanning fluorescence microscopy study of ion channel clusters in cardiac myocyte membranes. , 2004, Biophysical journal.

[52]  L. Tauzin,et al.  Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation , 2016, ACS nano.

[53]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[54]  Mark J. Ratain,et al.  Tumour heterogeneity in the clinic , 2013, Nature.

[55]  M. Collado,et al.  Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells. , 2017, ACS nano.

[56]  M. Nakamoto,et al.  Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines , 2007, Clinical Cancer Research.

[57]  D. Frenkel,et al.  Mobile linkers on DNA-coated colloids: valency without patches. , 2014, Physical review letters.

[58]  Robert Langer,et al.  Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. , 2011, Biomaterials.

[59]  T. Jovanović-Talisman,et al.  Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2 , 2018, Scientific Reports.

[60]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Fang Huang,et al.  Three-Dimensional Single-Molecule Localization Microscopy in Whole-Cell and Tissue Specimens. , 2020, Annual review of biomedical engineering.

[62]  D. Peckys,et al.  The 2018 correlative microscopy techniques roadmap , 2018, Journal of physics D: Applied physics.

[63]  Gur Pines,et al.  The ERBB network: at last, cancer therapy meets systems biology , 2012, Nature Reviews Cancer.

[64]  J. Driskell,et al.  Quantifying Bound and Active Antibodies Conjugated to Gold Nanoparticles: A Comprehensive and Robust Approach To Evaluate Immobilization Chemistry , 2018, ACS omega.

[65]  Luigi Calzolai,et al.  Determination of the structure and morphology of gold nanoparticle-HSA protein complexes. , 2015, Nanoscale.

[66]  Mark M Banaszak Holl,et al.  Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation. , 2011, Accounts of chemical research.

[67]  E. W. Meijer,et al.  A stochastic view on surface inhomogeneity of nanoparticles , 2019, Nature Communications.

[68]  Lei Shen,et al.  Quantification of Multivalency in Protein-Oligomer-Coated Nanoparticles Targeting Dynamic Membrane Glycan Receptors. , 2018, Langmuir : the ACS journal of surfaces and colloids.

[69]  Z. Fayad,et al.  Nanoimmunotherapy to treat ischaemic heart disease , 2018, Nature Reviews Cardiology.

[70]  Dan Peer,et al.  Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.

[71]  Serena Mazzucchelli,et al.  Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies , 2016, Nature Communications.

[72]  Wei Wang,et al.  Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging. , 2015, Analytical chemistry.

[73]  Markus Haltmeier,et al.  Mapping molecules in scanning far-field fluorescence nanoscopy , 2015, Nature Communications.

[74]  Aristidis M. Tsatsakis,et al.  Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: the cell and immune system , 2017, Particle and Fibre Toxicology.

[75]  P. Cicuta,et al.  Kinetics of Nanoparticle-Membrane Adhesion Mediated by Multivalent Interactions. , 2019, Langmuir : the ACS journal of surfaces and colloids.

[76]  Gert Storm,et al.  The role of liposomes in clinical nanomedicine development. What now? Now what? , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[77]  Marina S. Dietz,et al.  Optical super-resolution microscopy unravels the molecular composition of functional protein complexes. , 2019, Nanoscale.

[78]  Delyan R. Hristov,et al.  University of Groningen Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles , 2017 .

[79]  A. Perelson,et al.  Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment. , 2002, Mathematical biosciences.

[80]  Nicholas B. Tito,et al.  First-order ‘hyper-selective’ binding transition of multivalent particles under force , 2019, Journal of physics. Condensed matter : an Institute of Physics journal.

[81]  Antoine M. van Oijen,et al.  Quantification of ligand density and stoichiometry on the surface of liposomes using single‐molecule fluorescence imaging , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[82]  I. Voets,et al.  Super-resolution microscopy as a powerful tool to study complex synthetic materials , 2019, Nature Reviews Chemistry.

[83]  R. Kane,et al.  Characterization of the diffusion of epidermal growth factor receptor clusters by single particle tracking. , 2013, Biochimica et biophysica acta.

[84]  P. Thordarson,et al.  Multivalency in Drug Delivery-When Is It Too Much of a Good Thing? , 2019, Bioconjugate chemistry.

[85]  Thomas Lars Andresen,et al.  Modulating the antibody density changes the uptake and transport at the blood‐brain barrier of both transferrin receptor‐targeted gold nanoparticles and liposomal cargo , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[86]  G. Turashvili,et al.  Tumor Heterogeneity in Breast Cancer , 2017, Front. Med..

[87]  L. Johnston,et al.  Imaging nanometer domains of β-adrenergic receptor complexes on the surface of cardiac myocytes , 2005, Nature chemical biology.

[88]  R. Netz,et al.  Quantitative Prediction of Multivalent Ligand-Receptor Binding Affinities for Influenza, Cholera, and Anthrax Inhibition. , 2018, ACS nano.

[89]  C. A. Che Abdullah,et al.  A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment , 2017, International journal of nanomedicine.

[90]  A. Tkachenko,et al.  Kinetic limitations of cooperativity-based drug delivery systems. , 2007, Physical review letters.

[91]  David L Rimm,et al.  Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. , 2003, Cancer research.

[92]  A. Popel,et al.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. , 2011, Experimental cell research.

[93]  Stefano Angioletti-Uberti,et al.  Theory, simulations and the design of functionalized nanoparticles for biomedical applications: A Soft Matter Perspective , 2017, npj Computational Materials.

[94]  N. Gagey-Eilstein,et al.  Controlling Ligand Surface Density on Streptavidin-Magnetic Particles by a Simple, Rapid, and Reliable Chemiluminescent Test. , 2018, Bioconjugate chemistry.

[95]  C. Lim,et al.  Rapid quantification of live cell receptors using bioluminescence in a flow-based microfluidic device. , 2015, Small.

[96]  Sang Kyu Kwak,et al.  Cloaking nanoparticles with protein corona shield for targeted drug delivery , 2018, Nature Communications.

[97]  Iseult Lynch,et al.  Best practice in reporting corona studies: Minimum information about Nanomaterial Biocorona Experiments (MINBE). , 2019, Nano today.

[98]  D. Frenkel,et al.  A general theory of DNA-mediated and other valence-limited colloidal interactions. , 2012, The Journal of chemical physics.

[99]  Nicholas B. Tito,et al.  Switch-like surface binding of competing multivalent particles , 2016, 1604.04787.

[100]  M. Trepel,et al.  Differential organization of tonic and chronic B cell antigen receptors in the plasma membrane , 2019, Nature Communications.

[101]  Mark Bates,et al.  Multicolor Super-Resolution Imaging with Photo-Switchable Fluorescent Probes , 2007, Science.

[102]  C. Buske,et al.  Super-Resolution Microscopy Unveils Dynamic Heterogeneities in Nanoparticle Protein Corona. , 2017, Small.

[103]  Isuru D. Jayasinghe,et al.  True Molecular Scale Visualization of Variable Clustering Properties of Ryanodine Receptors , 2018, Cell reports.

[104]  P. Decuzzi,et al.  Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG-Pairing. , 2020, Nano letters.

[105]  M. Heilemann,et al.  Receptor-ligand interactions: binding affinities studied by single-molecule and super-resolution microscopy on intact cells. , 2014, Chemphyschem : a European journal of chemical physics and physical chemistry.

[106]  P. Lenz,et al.  Quantitative Particle Uptake by Cells as Analyzed by Different Methods , 2019, Angewandte Chemie.

[107]  T. Park,et al.  Diverse Applications of Nanomedicine , 2017, ACS nano.

[108]  D. Fletcher,et al.  Influenza A virus surface proteins are organized to help penetrate host mucus , 2019, bioRxiv.

[109]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[110]  M. E. Leunissen,et al.  The entropic impact of tethering, multivalency and dynamic recruitment in systems with specific binding groups , 2013 .

[111]  J. Storhoff,et al.  A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.

[112]  K. Hamad-Schifferli,et al.  Physical Properties of Biomolecules at the Nanomaterial Interface. , 2018, The journal of physical chemistry. B.

[113]  D. Frenkel,et al.  Design Principles for Super Selectivity using Multivalent Interactions , 2016, 1608.01222.

[114]  S. Jakobs,et al.  STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue , 2014, PloS one.

[115]  Youxin Li,et al.  Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo , 2018, International journal of nanomedicine.

[116]  Lauren E. Marbella,et al.  Ligand density quantification on colloidal inorganic nanoparticles. , 2016, The Analyst.

[117]  W. Jiskoot,et al.  Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[118]  G. Roviello,et al.  Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer , 2019, Cancers.

[119]  Vandana G Abramson,et al.  Molecular Heterogeneity of Triple-Negative Breast Cancer , 2014, Current Breast Cancer Reports.

[120]  S. Mitragotri,et al.  Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm , 2014, ACS nano.

[121]  D. Rimm,et al.  Automated subcellular localization and quantification of protein expression in tissue microarrays , 2002, Nature Medicine.

[122]  Ali Ahmed,et al.  Myocardial beta‐1 adrenoceptor down‐regulation in aging and heart failure: implications for beta‐blocker use in older adults with heart failure , 2003, European journal of heart failure.

[123]  M. C. Guimarães,et al.  Impact of conjugation strategies for targeting of antibodies in gold nanoparticles for ultrasensitive detection of 17β-estradiol , 2019, Scientific Reports.

[124]  Isaiah J. Fidler,et al.  The challenge of targeting metastasis , 2015, Cancer and Metastasis Reviews.

[125]  Nicholas G Welch,et al.  Orientation and characterization of immobilized antibodies for improved immunoassays (Review). , 2017, Biointerphases.

[126]  L. Albertazzi,et al.  Super-resolution Imaging of Structure, Molecular Composition, and Stability of Single Oligonucleotide Polyplexes , 2019, Nano letters.

[127]  Bing-he Xu,et al.  Targeted therapeutic options and future perspectives for HER2-positive breast cancer , 2019, Signal Transduction and Targeted Therapy.

[128]  Edmund J. Crampin,et al.  Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.

[129]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[130]  P. Imoukhuede,et al.  Single-Cell Receptor Quantification of an In Vitro Coculture Angiogenesis Model Reveals VEGFR, NRP1, Tie2, and PDGFR Regulation and Endothelial Heterogeneity , 2019, Processes.

[131]  Vito Mennella,et al.  Super-Resolution Microscopy: From Single Molecules to Supramolecular Assemblies. , 2015, Trends in cell biology.

[132]  Mauro Ferrari,et al.  Frontiers in cancer nanomedicine: directing mass transport through biological barriers. , 2010, Trends in biotechnology.

[133]  D. Frenkel,et al.  Communication: a simple analytical formula for the free energy of ligand-receptor-mediated interactions. , 2012, The Journal of chemical physics.

[134]  T. Kiziltepe,et al.  Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering. , 2017, Nanoscale.

[135]  Amanda K. Pearce,et al.  Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine. , 2019, Bioconjugate chemistry.

[136]  C. van Nostrum,et al.  Insights into maleimide‐thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[137]  J. Wysolmerski,et al.  HER2 signaling regulates HER2 localization and membrane retention , 2017, PloS one.

[138]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[139]  S. Mitragotri,et al.  Targeting Strategies for Tissue-Specific Drug Delivery , 2020, Cell.

[140]  H. Einsele,et al.  Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T , 2019, Nature Communications.

[141]  R. Kane,et al.  A Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density. , 2020, ACS nano.

[142]  A. J. Tavares,et al.  Synthesis of Patient-Specific Nanomaterials. , 2018, Nano letters.

[143]  A. V. Chernyshev,et al.  Distribution function approach to the study of the kinetics of IgM antibody binding to FcγRIIIb (CD16b) receptors on neutrophils by flow cytometry. , 2011, Journal of theoretical biology.

[144]  D. Schaffer,et al.  Multivalent ligands to control stem cell behaviour in vitro and in vivo , 2013, Nature nanotechnology.

[145]  Jonathan Wang,et al.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. , 2017, Biomaterials science.

[146]  Hongbin Ji,et al.  Mechanistic insights into EGFR membrane clustering revealed by super-resolution imaging. , 2015, Nanoscale.

[147]  P. Bolhuis,et al.  Rotational diffusion affects the dynamical self-assembly pathways of patchy particles , 2015, Proceedings of the National Academy of Sciences.

[148]  R. Schiff,et al.  Targeting HER2 for the treatment of breast cancer. , 2015, Annual review of medicine.

[149]  P. Cicuta,et al.  Membrane Adhesion through Bridging by Multimeric Ligands. , 2017, Langmuir : the ACS journal of surfaces and colloids.

[150]  Hans H. Gorris,et al.  Advances in Optical Single‐Molecule Detection: En Route to Supersensitive Bioaffinity Assays , 2019, Angewandte Chemie.

[151]  Edmund J. Crampin,et al.  Revisiting cell-particle association in vitro: A quantitative method to compare particle performance. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[152]  Tine Curk,et al.  Bonding interactions between ligand-decorated colloidal particles , 2018, Molecular Physics.

[153]  M. Sauer,et al.  Super-resolution imaging reveals the nanoscale organization of metabotropic glutamate receptors at presynaptic active zones , 2020, Science Advances.

[154]  R. Lipowsky,et al.  Binding equilibrium and kinetics of membrane-anchored receptors and ligands in cell adhesion: Insights from computational model systems and theory , 2016, Cell adhesion & migration.

[155]  A. Mason,et al.  Crystal structures of two mutants (K206Q, H207E) of the N‐lobe of human transferrin with increased affinity for iron , 2008, Protein science : a publication of the Protein Society.

[156]  P. R. ten Wolde,et al.  Generalised expressions for the association and dissociation rate constants of molecules with multiple binding sites , 2018 .

[157]  Yunze Yang,et al.  Label-free measuring and mapping of binding kinetics of membrane proteins in single living cells. , 2012, Nature chemistry.

[158]  Jurriaan Huskens,et al.  A model for describing the thermodynamics of multivalent host-guest interactions at interfaces. , 2004, Journal of the American Chemical Society.

[159]  R. Jain,et al.  Brain Cancer Receptors and Targeting Strategies , 2019, Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis.

[160]  R. M. Owen,et al.  Selective tumor cell targeting using low-affinity, multivalent interactions. , 2007, ACS chemical biology.

[161]  D. Frenkel,et al.  Superselective Targeting Using Multivalent Polymers , 2014, Journal of the American Chemical Society.

[162]  A C Marques,et al.  Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[163]  A. Salvati,et al.  Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine , 2020, Beilstein journal of nanotechnology.

[164]  Pablo Del Pino,et al.  Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates. , 2011, ACS nano.

[165]  Brad J Berron,et al.  A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells , 2015, Breast cancer : basic and clinical research.

[166]  L. Albertazzi,et al.  Nanoscale Mapping Functional Sites on Nanoparticles by Points Accumulation for Imaging in Nanoscale Topography (PAINT). , 2018, ACS nano.

[167]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[168]  Shihu Wang,et al.  Selectivity of ligand-receptor interactions between nanoparticle and cell surfaces. , 2012, Physical review letters.

[169]  Dan Peer,et al.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.

[170]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[171]  D. Frenkel,et al.  Re-entrant melting as a design principle for DNA-coated colloids. , 2012, Nature materials.

[172]  P. Swaan,et al.  Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.

[173]  Min-Yuan Chou,et al.  Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy , 2015, International journal of nanomedicine.

[174]  Alexander A. Chubykin,et al.  Three-dimensional nanoscopy of whole cells and tissues with in situ point spread function retrieval , 2020, Nature Methods.

[175]  G. I. Bell Models for the specific adhesion of cells to cells. , 1978, Science.

[176]  Kai Ludwig,et al.  Size dependence of steric shielding and multivalency effects for globular binding inhibitors. , 2015, Journal of the American Chemical Society.

[177]  Peng Yin,et al.  Optical visualisation of individual biomolecules in densely packed clusters , 2016 .

[178]  Christine Vauthier,et al.  Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[179]  D. Frenkel,et al.  Optimal multivalent targeting of membranes with many distinct receptors , 2017, Proceedings of the National Academy of Sciences.

[180]  C. Morasso,et al.  HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. , 2010, Pharmacological research.

[181]  L. A. Lane Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles , 2020 .

[182]  J. Seoane,et al.  The challenge of intratumour heterogeneity in precision medicine , 2014, Journal of internal medicine.

[183]  H. Han,et al.  Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer , 2019, Journal of Drug Delivery Science and Technology.

[184]  D. Shaw,et al.  A Simple Model of Multivalent Adhesion and Its Application to Influenza Infection , 2016, Biophysical journal.

[185]  J. Weaver,et al.  Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques , 2014, International journal of nanomedicine.

[186]  Wenwan Zhong,et al.  High-throughput profiling of nanoparticle-protein interactions by fluorescamine labeling. , 2015, Analytical chemistry.

[187]  Bradford G Orr,et al.  A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. , 2010, ACS nano.

[188]  A S Perelson,et al.  Aggregation of cell surface receptors by multivalent ligands , 1982, Journal of mathematical biology.

[189]  Johannes B. Woehrstein,et al.  Quantitative Super-Resolution Imaging with qPAINT using Transient Binding Analysis , 2016, Nature Methods.

[190]  J. Cochran,et al.  Targeting ligand-receptor interactions for development of cancer therapeutics. , 2017, Current opinion in chemical biology.

[191]  D. Pine,et al.  Crystallization of DNA-coated colloids , 2015, Nature Communications.

[192]  David J. Harrison,et al.  Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence , 2011, Journal of visualized experiments : JoVE.

[193]  M. Sliwkowski,et al.  Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.

[194]  Daan Frenkel,et al.  Theory and simulation of DNA-coated colloids: a guide for rational design. , 2016, Physical chemistry chemical physics : PCCP.

[195]  M. Sauer,et al.  Whole-cell imaging of plasma membrane receptors by 3D lattice light-sheet dSTORM , 2020, Nature Communications.

[196]  Matthew B Stone,et al.  Super-Resolution Microscopy: Shedding Light on the Cellular Plasma Membrane. , 2017, Chemical reviews.

[197]  V. Muzykantov,et al.  Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.

[198]  Yao Lu,et al.  Recruitment of receptors at supported lipid bilayers promoted by the multivalent binding of ligand-modified unilamellar vesicles† , 2020, Chemical science.

[199]  C. Dumontet,et al.  Strategies and challenges for the next generation of antibody–drug conjugates , 2017, Nature Reviews Drug Discovery.

[200]  N. Iqbal,et al.  Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications , 2014, Molecular biology international.

[201]  W. Mark Saltzman,et al.  Nanomedicine gets personal , 2015, Science Translational Medicine.

[202]  V. Dravid,et al.  Size-Selective Nanoparticle Assembly on Substrates by DNA Density Patterning. , 2016, ACS nano.

[203]  Nicholas B. Tito,et al.  Multivalent "attacker and guard" strategy for targeting surfaces with low receptor density. , 2018, The Journal of chemical physics.

[204]  Alfredo Cesario,et al.  Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance , 2016, International journal of molecular sciences.

[205]  E. Crampin,et al.  An analytical approach for quantifying the influence of nanoparticle polydispersity on cellular delivered dose , 2018, Journal of The Royal Society Interface.

[206]  C. Scott,et al.  Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy. , 2018, Drug discovery today. Technologies.

[207]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[208]  E. Jones,et al.  Cell guidance ligands, receptors and complexes – orchestrating signalling in time and space , 2019, Current opinion in structural biology.

[209]  B. M. Mognetti,et al.  Surface-triggered cascade reactions between DNA linkers direct the self-assembly of colloidal crystals of controllable thickness. , 2018, Nanoscale.

[210]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.

[211]  A. Šarić,et al.  On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias , 2020, Science Advances.

[212]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[213]  Peter Wick,et al.  Addition of nanoscaled bioinspired surface features: A revolution for bone related implants and scaffolds? , 2014, Journal of biomedical materials research. Part A.

[214]  J. Lippincott-Schwartz,et al.  Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.

[215]  A. Perelson,et al.  Equilibrium binding of multivalent ligands to cells: effects of cell and receptor density. , 1995, Mathematical biosciences.

[216]  Tal Dvir,et al.  Nanoparticles targeting the infarcted heart. , 2011, Nano letters.

[217]  Jonathan T. C. Liu,et al.  Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging , 2015, Physics in medicine and biology.

[218]  Kristofer J Thurecht,et al.  Recent Advances in the Generation of Antibody–Nanomaterial Conjugates , 2018, Advanced healthcare materials.

[219]  Christian Eggeling,et al.  STED microscopy reveals crystal colour centres with nanometric resolution. , 2009 .

[220]  Raquel Ferreira,et al.  Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[221]  A. Misra,et al.  Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells , 2018, Journal of microencapsulation.

[222]  A. Johnston,et al.  Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency. , 2019, Nano letters.

[223]  D. Frenkel,et al.  Multivalent Recognition at Fluid Surfaces: The Interplay of Receptor Clustering and Superselectivity. , 2019, Journal of the American Chemical Society.

[224]  N. Seeman,et al.  Sequential self-assembly of DNA functionalized droplets , 2017, Nature Communications.

[225]  Claudio Parolo,et al.  Design, preparation, and evaluation of a fixed-orientation antibody/gold-nanoparticle conjugate as an immunosensing label. , 2013, ACS applied materials & interfaces.

[226]  B. Różycki,et al.  Binding cooperativity of membrane adhesion receptors , 2009, 0906.0462.

[227]  T. H. Evers,et al.  The influence of covalent immobilization conditions on antibody accessibility on nanoparticles. , 2017, The Analyst.

[228]  Kinam Park The drug delivery field at the inflection point: Time to fight its way out of the egg , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[229]  J. Driskell,et al.  pH Impacts the Orientation of Antibody Adsorbed onto Gold Nanoparticles. , 2019, Bioconjugate chemistry.

[230]  Cristina Fornaguera,et al.  Personalized Nanomedicine: A Revolution at the Nanoscale , 2017, Journal of personalized medicine.

[231]  K. Dawson,et al.  In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry , 2016, Nature Communications.

[232]  S. Wilhelm,et al.  Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. , 2019, Advanced drug delivery reviews.

[233]  Joseph L. Goldstein,et al.  Recycling receptors: The round-trip itinerary of migrant membrane proteins , 1983, Cell.

[234]  Huile Gao,et al.  The impact of protein corona on the behavior and targeting capability of nanoparticle‐based delivery system , 2018, International journal of pharmaceutics.

[235]  Batakrishna Jana,et al.  Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona , 2020, Advanced Therapeutics.

[236]  Ming Fang,et al.  Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions. , 2010, Macromolecules.

[237]  F. Caruso,et al.  Particle Targeting in Complex Biological Media , 2018, Advanced healthcare materials.

[238]  Bortolo Matteo Mognetti,et al.  Bond formation kinetics affects self-assembly directed by ligand-receptor interactions. , 2016, Soft matter.

[239]  Abbas Shirinifard,et al.  Correlative three-dimensional super-resolution and block-face electron microscopy of whole vitreously frozen cells , 2020, Science.

[240]  Susan Hua,et al.  Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization , 2018, Front. Pharmacol..

[241]  P. Bolhuis,et al.  The role of multivalency in the association kinetics of patchy particle complexes. , 2017, The Journal of chemical physics.

[242]  T. Behnke,et al.  Streptavidin conjugation and quantification—a method evaluation for nanoparticles , 2016, Analytical and Bioanalytical Chemistry.

[243]  Alaaldin M. Alkilany,et al.  Ligand density on nanoparticles: A parameter with critical impact on nanomedicine. , 2019, Advanced drug delivery reviews.

[244]  Morteza Mahmoudi,et al.  Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.